Table 9.
Percentage of hearts presenting LVNC according to Chin, Jenni, and Petersen when stratified by sex (apex).
| CHD | Chin | Jenni | Petersen | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | OR (95% CI) | p-Value | Male | Female | OR (95% CI) | p-Value | Male | Female | OR (95% CI) | p-Value | |
| VSD | 41.7% (10/24) | 68.2% (15/22) | 3.00 (0.89–10.06) | 0.0852 | 25.0% (6/24) | 45.5% (10/22) | 2.50 (0.72–8.71) | 0.2167 | 0.0% (0/24) | 22.7% (5/22) | 15.40 (0.80–297.2) | 0.0192 |
| ASD | 25.0% (1/4) | 0.0% (0/6) | 0.17 (0.01–5.68) | 0.4000 | 25.0% (1/4) | 0.0% (0/6) | 0.18 (0.01–5.68) | 0.4000 | 25.0% (1/4) | 0.0% (0/6) | 0.18 (0.01–5.68) | 0.4000 |
| AVSD | 7.1% (1/14) | 0.0% (0/20) | 0.22 (0.01–5.80) | 0.4118 | 7.1% (1/14) | 0.0% (0/20) | 0.22 (0.01–5.80) | 0.4118 | 0.0% (0/14) | 0.0% (0/20) | 0.70 (0.01–37.79) | 1.0000 |
| TGA | 18.8% (6/32) | 25.0% (5/20) | 1.44 (0.38–5.55) | 0.7300 | 15.6% (5/32) | 15% (3/20) | 0.95 (0.20–4.51) | 1.0000 | 3.1% (1/32) | 10% (2/20) | 3.44 (0.29–40.74) | 0.5511 |
| Isomerism | 10.0% (1/10) | 5.9% (1/17) | 0.56 (0.03–10.12) | 1.0000 | 10.0% (1/10) | 5.9% (1/17) | 0.56 (0.03–10.12) | 1.0000 | 10.0% (1/10) | 5.9% (1/17) | 0.56 (0.03–10.12) | 1.0000 |
| Ebstein | 14.3% (1/7) | 35.7% (5/14) | 3.33 (0.31–36.13) | 0.6126 | 0.0% (0/7) | 14.3% (2/14) | 3.00 (0.13–71.37) | 0.5333 | 0.0% (0/7) | 0.0% (0/14) | 0.52 (0.01–28.78) | 1.0000 |
| Fallot | 11.1% (2/18) | 0.0% (0/16) | 0.20 (0.01–4.50) | 0.8889 | 15.6% (1/18) | 0.0% (0/16) | 0.35 (0.01–9.31) | 1.0000 | 15.6% (1/18) | 0.0% (0/16) | 0.35 (0.01–9.31) | 1.0000 |
| TOTAL | 20.2% (22/109) | 22.6% (26/115) | 1.06 (0.90–1.24) | 0.7551 | 13.8% (15/109) | 13.9% (16/115) | 1.01 (0.47–2.16) | 1.0000 | 3.7% (4/109) | 7.0% (8/115) | 1.963 (0.57–6.71) | 0.3766 |
Not applicable for normal hearts.